SWEETNAM PAUL (Chief Scientific Officer) reported 2 transactions at RETENSION PHARMACEUTICALS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 10/13/2026ACC: 0001213900-26-109159
Officer· Chief Scientific Officer
Since Oct 2026
0.00
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
4
Total transactions
6.67K acquired · 6.67K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+4.03K
Price / share
—
Trade value
—
% of position
1.0%
10/13/2026
402.58K→406.60K
Common Stock
Indirect
Shares
+2.64K
Price / share
—
Trade value
—
% of position
New position
10/13/2026
0.00→2.64K
Total
Net shares
+6.67K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/13/2026 | C · Conversion | +4.03K | — | — | 1.0% | 402.58K | 406.60K |
| Common Stock Indirect | 10/13/2026 | C · Conversion | +2.64K | — | — | New position | 0.00 | 2.64K |
| Total | +6.67K | $0.00 | ||||||
Derivative Transactions2
Series A Convertible Preferred Stock
Direct
Converts to
Common Stock
4.03K shares
Shares
−4.03K
Strike price
Held after
0.00
Exercisable
—
10/13/2026
Series B Convertible Preferred Stock
Indirect
Converts to
Common Stock
2.64K shares
Shares
−2.64K
Strike price
Held after
0.00
Exercisable
—
10/13/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Series A Convertible Preferred Stock Direct | Common Stock4.03K shares | 10/13/2026 | C · Conversion | −4.03K | — | 0.00 | |
| Series B Convertible Preferred Stock Indirect | Common Stock2.64K shares | 10/13/2026 | C · Conversion | −2.64K | — | 0.00 |